Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released Nov 6, 2018, after the close
10-Q filed Nov 6, 2018, 37 days after period end · 0001558370-18-008641
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $65.69M | $86.83M | $66.11M | $39.57M |
| Net Income | -$174.35M | -$32.30M | -$33.20M | — |
| EPS Diluted | -$1.14 |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| -$0.22 |
| -$0.23 |
| -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.